8-K: Jaguar Health Secures Waiver to Allow ATM Offering Despite Prior Agreement

Jaguar Health obtains a limited waiver from investors to proceed with an at-the-market offering, despite a previous agreement restricting variable rate transactions.

Summary

• Jaguar Health, Inc. has obtained a limited waiver from investors holding a majority of its securities.
• This waiver allows the company to proceed with sales of its common stock through an At-The-Market (ATM) offering, despite a prior restriction.
• The restriction, outlined in securities purchase agreements from March 26, 2025, prohibited Jaguar Health from engaging in Variable Rate Transactions (VRTs) for one year after the registration statement for the resale of common stock was declared effective.
• The waiver specifically addresses Section 5(n) of the Purchase Agreement, which restricted the issuance of common stock or common stock equivalents involving a VRT, including an at-the-market offering.
• The ATM offering is conducted under an agreement with Ladenburg Thalmann & Co. Inc. and Lucid Capital Markets, LLC.
• The company has filed a prospectus supplement with the SEC related to the ATM program.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the waiver provides financial flexibility, but the reliance on ATM offerings can be dilutive.

Positives

• The waiver provides Jaguar Health with increased flexibility to raise capital through its ATM offering.
• The company can now access the market to sell shares of common stock under the ATM Agreement.
• The waiver was approved by investors holding a majority of the Securities, indicating support for the company's strategy.

Risks

• The company's ability to raise capital through the ATM offering is subject to market conditions and investor demand.
• Continued reliance on ATM offerings may dilute existing shareholders' equity.
• The waiver is limited and does not remove all restrictions on Variable Rate Transactions.

Future Outlook

The company intends to continue utilizing the ATM offering to raise capital, subject to market conditions and investor demand.

Industry Context

ATM offerings are a common method for small-cap companies to raise capital, providing flexibility but also potentially leading to dilution. The waiver allows Jaguar Health to align its financing strategy with current market opportunities.

Comparison to Industry Standards

• Many small-cap biotech companies use ATM offerings to fund operations and research.
• Comparable companies like Zomedica and Ocugen have also utilized ATM offerings to raise capital.
• The terms of Jaguar Health's ATM offering and related agreements appear to be within industry norms for similar companies.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares through the ATM offering.
• The company's ability to raise capital could benefit employees and other stakeholders by ensuring continued operations.

Next Steps

• The company will continue to offer and sell shares of its common stock under the ATM Agreement.
• Jaguar Health will file a supplement to the ATM Prospectus Supplement with the SEC.

Key Dates

Keywords

Jaguar Health, ATM offering, waiver, securities purchase agreement, variable rate transaction, common stock, Ladenburg Thalmann, Lucid Capital Markets, capital raise